Literature DB >> 6347150

Early-onset pauciarticular juvenile rheumatoid arthritis. A histopathologic study.

J C Merriam, L T Chylack, D M Albert.   

Abstract

A young girl with early-onset pauciarticular juvenile rheumatoid arthritis suffered from recurrent severe bilateral iridocyclitis. Despite intensive medical therapy, she gradually lost all useful vision and ultimately required bilateral enucleation at the age of 10 years for control of pain and photophobia. Histopathologic study of the eyes revealed in the iris and ciliary body a dense inflammatory infiltrate composed principally of plasma cells, as well as angle closure, a dense cyclitic membrane, retinal detachment, cystoid macula, and optic atrophy. Immunoperoxidase stains showed little immunoglobulin within or around the plasma cells within the ciliary body, although strong reactions for IgG and kappa- and lambda-light chains were seen in other parts of the eyes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6347150     DOI: 10.1001/archopht.1983.01040020087015

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  4 in total

Review 1.  Juvenile chronic arthritis, chronic iridocyclitis, and reactivity to histones.

Authors:  A M Leak; P Woo
Journal:  Ann Rheum Dis       Date:  1991-09       Impact factor: 19.103

Review 2.  A Review of the Various Roles and Participation Levels of B-Cells in Non-Infectious Uveitis.

Authors:  Lei Zhu; Binyao Chen; Wenru Su
Journal:  Front Immunol       Date:  2021-05-14       Impact factor: 7.561

Review 3.  Involvement of B cells in non-infectious uveitis.

Authors:  Justine R Smith; Andrew J Stempel; Arpita Bharadwaj; Binoy Appukuttan
Journal:  Clin Transl Immunology       Date:  2016-02-05

4.  Identification of Ocular Autoantigens Associated With Juvenile Idiopathic Arthritis-Associated Uveitis.

Authors:  Martin Busch; Kira Leona Wefelmeyer; Karoline Walscheid; Kai Rothaus; Dirk Bauer; Cornelia A Deeg; Roxane L Degroote; Doreen Ackermann; Simone König; Solon Thanos; Maren Kasper; Arnd Heiligenhaus
Journal:  Front Immunol       Date:  2019-08-06       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.